Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
1,131
Value
$61.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,131$61.7K<0.1%+546+93.3%AddedHolders
Q1 2026585$27.9K<0.1%−34−5.5%ReducedHolders
Q4 2025619$32.5K<0.1%+30+5.1%AddedHolders
Q3 2025589$38.2K<0.1%+51+9.5%AddedHolders
Q2 2025538$26.2K<0.1%+31+6.1%AddedHolders
Q1 2025507$17.2K<0.1%+67+15.2%AddedHolders
Q4 2024440$17.3K<0.1%00.0%UnchangedHolders
Q3 2024440$20.7K<0.1%−399−47.6%ReducedHolders
Q2 2024839$45.3K<0.1%+96+12.9%AddedHolders
Q1 2024743$50.6K<0.1%+391+111.1%AddedHolders
Q4 2023352$22.0K<0.1%+139+65.3%AddedHolders
Q3 2023213$9.67K<0.1%+20+10.4%AddedHolders
Q2 2023193$10.8K<0.1%00.0%UnchangedHolders
Q1 2023193$8.73K<0.1%−47−19.6%ReducedHolders
Q4 2022240$9.76K<0.1%−74−23.6%ReducedHolders
Q3 2022314$21.0K<0.1%−3−0.9%ReducedHolders
Q2 2022317$19.0K<0.1%+13+4.3%AddedHolders
Q1 2022304$19.0K<0.1%−100−24.8%ReducedHolders
Q4 2021404$31.0K<0.1%+74+22.4%AddedHolders
Q3 2021330$37.0K<0.1%−103−23.8%ReducedHolders
Q2 2021433$70.0K<0.1%+125+40.6%AddedHolders
Q1 2021308$38.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.